API introduced the second of its "next-generation" health and longevity products shortly after its successful introduction of AimEndurance for cardiovascular health
NEW YORK, Jan. 26 /PRNewswire/ -- AIM Pharmakon, Inc. (API), a New York-based company, announced today the introduction of the next generation of health and longevity products with AimCa++DONAN (TM), a new premium-quality liquid calcium mineral concentrate for bone development and bone-protective therapeutic regimen. The product is available directly from AIM Pharmakon, Inc., through the physician care market, in select retail outlets and through its affiliated company, Global Life Science, LLC USA. The key components of the product are derived through "Green Technology." The product is eco-friendly, completely natural with specific biophysiological features, bioavailable nutrients, and biodegradable components. Unique product features are: no preservatives, no artificial colors and no artificial flavors. Adequate intake of bioavailable calcium helps to achieve peak bone mass, strong teeth, and prevents the bone loss. AimCa++DONAN is ideal for athletes, women concerned with menopause in peri- and postmenopausal phases, baby-boomers and seniors needing extra calcium supplementation.
"The role of calcium in the pathogenesis of osteoporosis is significantly prominent. There is insufficient intake of dietary calcium and minerals in our diet, particularly in those with an active lifestyle. The high prevalence of osteoporosis, bone and dental-related diseases are observed in geographical regions with high dairy consumption. Proteins in dairy calcium sources aid in elevating the blood's acidic value. That leads to leaching of calcium from bones thereby weakening the bones. A high protein diet alarmingly aggravates the reduction in bone density. Additionally, lactose intolerance can limit the options of getting calcium from dairy sources. This product is formulated to a
|SOURCE AIM Pharmakon, Inc.|
Copyright©2009 PR Newswire.
All rights reserved